Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Apr 21
 -0.56 / -0.48%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 118.00, with a high estimate of 144.00 and a low estimate of 75.00. The median estimate represents a +1.11% increase from the last price of 116.70.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.33%
Growthannually 87.21%


Growthquarterly -0.06%
Growthannually 17.46%
Key to the earnings and sales forecast charts.